vs

Side-by-side financial comparison of CaliberCos Inc. (CWD) and NEXGEL, INC. (NXGL). Click either name above to swap in a different company.

CaliberCos Inc. is the larger business by last-quarter revenue ($4.1M vs $2.8M, roughly 1.5× NEXGEL, INC.). NEXGEL, INC. runs the higher net margin — -34.7% vs -188.3%, a 153.6% gap on every dollar of revenue. On growth, NEXGEL, INC. posted the faster year-over-year revenue change (-8.1% vs -52.5%). Over the past eight quarters, NEXGEL, INC.'s revenue compounded faster (48.6% CAGR vs -57.6%).

CaliberCos Inc. is a U.S.-headquartered alternative asset management firm focused primarily on real estate investments. It offers a diverse suite of investment vehicles covering commercial, residential, and industrial real estate assets, serving institutional investors, high-net-worth individuals, and retail clients across North America. It also delivers asset management, property operation, and value-add real estate development services to support consistent long-term returns for investors.

NEXGEL, INC. is a specialty consumer healthcare and medical technology firm that develops, manufactures and distributes ultra-gentle, irritation-free hydrogel products. Its offerings span over-the-counter skincare remedies, wound care solutions, and topical drug delivery platforms, serving consumer, clinical and pharmaceutical partner segments primarily across North America, with growing global distribution channels.

CWD vs NXGL — Head-to-Head

Bigger by revenue
CWD
CWD
1.5× larger
CWD
$4.1M
$2.8M
NXGL
Growing faster (revenue YoY)
NXGL
NXGL
+44.4% gap
NXGL
-8.1%
-52.5%
CWD
Higher net margin
NXGL
NXGL
153.6% more per $
NXGL
-34.7%
-188.3%
CWD
Faster 2-yr revenue CAGR
NXGL
NXGL
Annualised
NXGL
48.6%
-57.6%
CWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CWD
CWD
NXGL
NXGL
Revenue
$4.1M
$2.8M
Net Profit
$-7.7M
$-970.0K
Gross Margin
29.3%
Operating Margin
-196.6%
-43.4%
Net Margin
-188.3%
-34.7%
Revenue YoY
-52.5%
-8.1%
Net Profit YoY
32.2%
-14.1%
EPS (diluted)
$1.95
$-0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CWD
CWD
NXGL
NXGL
Q4 25
$4.1M
$2.8M
Q3 25
$3.6M
$2.9M
Q2 25
$5.1M
$2.9M
Q1 25
$7.3M
$2.8M
Q4 24
$8.7M
$3.0M
Q3 24
$11.3M
$2.9M
Q2 24
$8.2M
$1.4M
Q1 24
$23.0M
$1.3M
Net Profit
CWD
CWD
NXGL
NXGL
Q4 25
$-7.7M
$-970.0K
Q3 25
$-4.4M
$-653.0K
Q2 25
$-5.3M
$-665.0K
Q1 25
$-4.4M
$-712.0K
Q4 24
$-11.4M
$-850.0K
Q3 24
$146.0K
$-693.0K
Q2 24
$-4.7M
$-885.0K
Q1 24
$-3.8M
$-853.0K
Gross Margin
CWD
CWD
NXGL
NXGL
Q4 25
29.3%
Q3 25
42.4%
Q2 25
43.6%
Q1 25
42.3%
Q4 24
37.5%
Q3 24
39.3%
Q2 24
20.3%
Q1 24
12.6%
Operating Margin
CWD
CWD
NXGL
NXGL
Q4 25
-196.6%
-43.4%
Q3 25
-129.6%
-24.7%
Q2 25
-112.4%
-22.1%
Q1 25
-62.7%
-27.7%
Q4 24
-236.8%
-27.6%
Q3 24
0.0%
-26.8%
Q2 24
-65.0%
-73.2%
Q1 24
-22.9%
-68.8%
Net Margin
CWD
CWD
NXGL
NXGL
Q4 25
-188.3%
-34.7%
Q3 25
-120.2%
-22.3%
Q2 25
-104.5%
-23.1%
Q1 25
-60.7%
-25.4%
Q4 24
-247.6%
-27.9%
Q3 24
1.3%
-23.6%
Q2 24
-57.8%
-61.5%
Q1 24
-16.6%
-67.4%
EPS (diluted)
CWD
CWD
NXGL
NXGL
Q4 25
$1.95
$-0.12
Q3 25
$-1.65
$-0.08
Q2 25
$-4.15
$-0.09
Q1 25
$-3.85
$-0.09
Q4 24
$-10.15
$-0.11
Q3 24
$0.12
$-0.11
Q2 24
$-4.34
$-0.14
Q1 24
$-3.53
$-0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CWD
CWD
NXGL
NXGL
Cash + ST InvestmentsLiquidity on hand
$2.9M
Total DebtLower is stronger
$588.0K
Stockholders' EquityBook value
$1.3M
$4.5M
Total Assets
$135.4M
$10.5M
Debt / EquityLower = less leverage
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CWD
CWD
NXGL
NXGL
Q4 25
$2.9M
Q3 25
$10.9M
$938.0K
Q2 25
$683.0K
Q1 25
$1.6M
Q4 24
$2.3M
$1.8M
Q3 24
$1.6M
$1.1M
Q2 24
$1.8M
Q1 24
$2.1M
Total Debt
CWD
CWD
NXGL
NXGL
Q4 25
$588.0K
Q3 25
$614.0K
Q2 25
$638.0K
Q1 25
$662.0K
Q4 24
$685.0K
Q3 24
$709.0K
Q2 24
$732.0K
Q1 24
$750.0K
Stockholders' Equity
CWD
CWD
NXGL
NXGL
Q4 25
$1.3M
$4.5M
Q3 25
$4.2M
$5.2M
Q2 25
$-19.9M
$4.7M
Q1 25
$-15.8M
$5.2M
Q4 24
$-12.6M
$5.8M
Q3 24
$-3.8M
$4.7M
Q2 24
$-4.7M
$4.2M
Q1 24
$-745.0K
$4.8M
Total Assets
CWD
CWD
NXGL
NXGL
Q4 25
$135.4M
$10.5M
Q3 25
$82.6M
$11.6M
Q2 25
$59.3M
$9.7M
Q1 25
$103.6M
$10.4M
Q4 24
$105.5M
$11.0M
Q3 24
$158.6M
$10.6M
Q2 24
$195.2M
$9.8M
Q1 24
$201.5M
$10.4M
Debt / Equity
CWD
CWD
NXGL
NXGL
Q4 25
0.13×
Q3 25
0.12×
Q2 25
0.14×
Q1 25
0.13×
Q4 24
0.12×
Q3 24
0.15×
Q2 24
0.18×
Q1 24
0.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CWD
CWD
NXGL
NXGL
Operating Cash FlowLast quarter
$-12.1M
$281.0K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CWD
CWD
NXGL
NXGL
Q4 25
$-12.1M
$281.0K
Q3 25
$-4.6M
$-785.0K
Q2 25
$-1.2M
$-407.0K
Q1 25
$-1.7M
$-400.0K
Q4 24
$555.0K
$-859.0K
Q3 24
$-74.0K
$-1.2M
Q2 24
$1.4M
$-700.0K
Q1 24
$-1.5M
$-1.1M
Free Cash Flow
CWD
CWD
NXGL
NXGL
Q4 25
Q3 25
$-793.0K
Q2 25
Q1 25
Q4 24
Q3 24
$-1.2M
Q2 24
$-909.0K
Q1 24
$-1.2M
FCF Margin
CWD
CWD
NXGL
NXGL
Q4 25
Q3 25
-27.0%
Q2 25
Q1 25
Q4 24
Q3 24
-41.8%
Q2 24
-63.1%
Q1 24
-98.3%
Capex Intensity
CWD
CWD
NXGL
NXGL
Q4 25
Q3 25
0.3%
Q2 25
Q1 25
Q4 24
Q3 24
0.4%
Q2 24
14.5%
Q1 24
12.0%
Cash Conversion
CWD
CWD
NXGL
NXGL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-0.51×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons